Stem Cell Therapies for Cardiac Disease: Which Cell Types Are the Best

Stem cell therapy for the treatment of cardiovascular disease is increasingly being researched during the past few decades. Due to the risk of cardiac transplantation surgery and the nature of cardiac cell lines, the regenerative potential of stem cell therapy is being extremely expected. Popular cell lines are discussed in this study, which includes mesenchymal stem cells, bone marrow-derived mononuclear stem cells, embryonic stem cells, hematopoietic stem cells, endothelial progenitor cells, tissue-specific stem cells, umbilical cord blood stem cells, skeletal myoblast and induced pluripotent stem cells. The purpose of this study is to review the current use of various cell types for stem cell therapy in cardiovascular patients, as mentioned above. Additionally, optimal delivery methods of stem cell therapies are also discussed in patients with and without secondary stroke conditions. Literature from the Internet was searched and primary studies with the cell types of interest were carefully examined and included in the study. Although from current literature in the field stem cell therapies have great potential to be used in cardiovascular patients, more extensive research with a greater number is warranted before widespread application in the clinical setting.

• Publication year

  2021

• Venue

  International Conference on Bioinformatics and Biomedical Science

• Publication date

  2021-10-29

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1145/3498731.3498762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Stem Cell Therapies in Cardiovascular Disease.

  2019cited by this paper
• Transplantation of Human-induced Pluripotent Stem Cell-derived Cardiomyocytes Is Superior to Somatic Stem Cell Therapy for Restoring Cardiac Function and Oxygen Consumption in a Porcine Model of Myocardial Infarction

  2019cited by this paper
• Endothelial Progenitor Cells and Cardiovascular Correlates

  2018cited by this paper
• Unproven Stem Cell Therapies in India: Regulatory Challenges and Proposed Paths Forward.

  2018cited by this paper
• Ethical and Safety Issues of Stem Cell-Based Therapy

  2018cited by this paper
• Stem Cell Therapy for Articular Cartilage Repair: Review of the Entity of Cell Populations Used and the Result of the Clinical Application of Each Entity

  2018cited by this paper
• Advances and challenges in stem cell culture.

  2017cited by this paper
• Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD.

  2017cited by this paper
• Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association

  2017cited by this paper
• A History of Cord Blood Banking and Transplantation

  2017cited by this paper
• Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction

  2017cited by this paper
• Advances in stem cell therapy for cardiovascular disease (Review)

  2016influential reference
• Stem Cell Therapy and Administration Routes After Stroke

  2016cited by this paper
• Cardiac Stem Cell Treatment in Myocardial Infarction: A Systematic Review and Meta-Analysis of Preclinical Studies.

  2016cited by this paper
• Treatment of Macular Degeneration Using Embryonic Stem Cell-Derived Retinal Pigment Epithelium: Preliminary Results in Asian Patients

  2015cited by this paper
• Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease

  2015influential reference
• The Dark Side of the Force – Constraints and Complications of Cell Therapies for Stroke

  2015cited by this paper
• Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine.

  2015cited by this paper
• Heart transplantation: review

  2015cited by this paper
• Paracrine Effect of Mesenchymal Stem Cells Derived from Human Adipose Tissue in Bone Regeneration

  2014cited by this paper
• Endothelial progenitor cells in cardiovascular diseases.

  2014cited by this paper
• Paracrine effects of stem cells in wound healing and cancer progression

  2014cited by this paper
• The Size of Mesenchymal Stem Cells is a Significant Cause of Vascular Obstructions and Stroke

  2014cited by this paper
• Stem cells for cardiac repair: an introduction

  2013cited by this paper
• Depression and Cardiac Disease: Epidemiology, Mechanisms, and Diagnosis

  2013cited by this paper
• Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.

  2012cited by this paper
• Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview.

  2012cited by this paper
• Clinical application of stem cell therapy in Parkinson's disease

  2012cited by this paper
• Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection.

  2012cited by this paper
• Heart repair by reprogramming non-myocytes with cardiac transcription factors

  2012cited by this paper
• Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.

  2011cited by this paper
• Depression and Cardiac Disease: A Review

  2011cited by this paper
• A collaborative care depression management program for cardiac inpatients: depression characteristics and in-hospital outcomes.

  2011cited by this paper
• Abstract 10466: In Vivo Reprogramming of Murine Cardiac Fibroblasts into Induced Cardiomyocytes

  2011cited by this paper
• Development of a Network to Test Strategies in Cardiovascular Cell Delivery: The NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN)

  2010cited by this paper
• Optimizing Stem Cell Culture

  2010cited by this paper
• Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI).

  2010cited by this paper
• Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.

  2010cited by this paper
• Repeated Mesenchymal Stem Cell Treatment after Neonatal Hypoxia–Ischemia Has Distinct Effects on Formation and Maturation of New Neurons and Oligodendrocytes Leading to Restoration of Damage, Corticospinal Motor Tract Activity, and Sensorimotor Function

  2010cited by this paper
• Human umbilical cord blood stem cells, myocardial infarction and stroke.

  2009cited by this paper
• Heart failure burden and therapy.

  2009cited by this paper
• Cardiac tissue engineering using stem cells.

  2009cited by this paper
• Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2009cited by this paper
• Dual-Modality Monitoring of Targeted Intraarterial Delivery of Mesenchymal Stem Cells After Transient Ischemia

  2008cited by this paper
• Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development.

  2008cited by this paper
• Dystrophin‐deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma

  2007cited by this paper
• Potential risks of bone marrow cell transplantation into infarcted hearts.

  2007cited by this paper
• Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model.

  2007cited by this paper
• A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke.

  2006cited by this paper
• Mesenchymal stem cells as trophic mediators

  2006cited by this paper
• Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.

  2006cited by this paper
• Stem cell therapy after myocardial infarction: ready for clinical application?

  2006cited by this paper
• Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters.

  2006cited by this paper
• Clinical use of umbilical cord blood hematopoietic stem cells.

  2006cited by this paper
• Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit.

  2006cited by this paper
• Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair

  2005cited by this paper
• Endothelial‐like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction

  2005cited by this paper
• Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets.

  2005cited by this paper
• Adult stem cell application in spinal cord injury.

  2005cited by this paper
• Direct cardiac injection of G-CSF mobilized bone-marrow stem-cells improves ventricular function in old myocardial infarction.

  2005cited by this paper
• Circulating endothelial progenitor cells and cardiovascular outcomes.

  2005cited by this paper
• Unexpected Severe Calcification After Transplantation of Bone Marrow Cells in Acute Myocardial Infarction

  2004cited by this paper
• Mesenchymal stem cells and their potential as cardiac therapeutics.

  2004cited by this paper
• Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow

  2004cited by this paper
• Nonmalignant late effects after allogeneic stem cell transplantation.

  2003cited by this paper
• Mesenchymal Progenitor Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Rat Cellular Cardiomyoplasty Model

  2003cited by this paper
• Full reconstitution of hematopoietic system by murine umbilical cord blood

  2003cited by this paper
• Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation.

  2003cited by this paper
• Cardiomyocyte cell cycle regulation.

  2002cited by this paper
• Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow.

  2002cited by this paper
• Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans

  2002cited by this paper
• Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats.

  2002cited by this paper
• Bone marrow cells regenerate infarcted myocardium

  2001cited by this paper
• Myoblast transplantation for heart failure.

  2001cited by this paper
• [Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction].

  2001cited by this paper
• Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia

  2001cited by this paper
• Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.

  2001cited by this paper
• Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation

  1998cited by this paper
• Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction.

  1997cited by this paper
• Skeletal myoblast transplantation for repair of myocardial necrosis.

  1996cited by this paper
• An updated coronary risk profile. A statement for health professionals.

  1991cited by this paper

• No citing papers are available for this paper.